Evaluation of the intervention for sleep disturbance and delirium prevention in critically ill patients

Evaluation of the intervention for sleep disturbance and delirium prevention in critically ill patients - Evaluation of the intervention for sleep disturbance and delirium prevention in critically ill patients

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000026350

Enrollment

160

Registered

2017-03-01

Start date

2017-03-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adult critically ill patients spending 72 hours or more in ICU

Interventions

Non-pharmacological sleep promotion bundle Medication with 15 or 20mg of suvorexant for the patients who 1)complaints sleepless or 2)takes preoperative hypnotic 3)objectively appears sleepless.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Adult critically ill patients spending 72 hours or more in ICU with informed consent

Exclusion criteria

Exclusion criteria: History of impairments on central nerve system Postresuscitation from cardiopulmonary arrest Psychiatric or dementia patients Alcoholic or drug abuse Pediatrics younger than 20 years Positive CAM-ICU on post-operative day 1

Design outcomes

Primary

Measure	Time frame
The incidence of delirium	—

Secondary

Measure	Time frame
Sleep structures, duration days of delirium, ventilator-free days at 28 days, length of stay in ICU, 28-day mortality	—

Countries

Japan

Contacts

Public ContactKanae NAGATOMO

Jichi Medical University Saitama Medical Center Anesthesia, Critical and General Surgery

nagatomo-cib@umin.ac.jp048-647-2111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026